bioAffinity Technologies, Inc. SEC filings BIAF

bioAffinity Technologies, Inc. has 399 filings in SEC EDGAR's recent list, going back to Jul 26, 2017. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.

bioAffinity Technologies, Inc. SEC filings
Form Description Filed Period
424B5 Prospectus supplement Nov 3, 2026 —
424B5 Prospectus supplement Nov 2, 2026 —
424B5 Prospectus supplement Oct 9, 2026 —
424B5 Prospectus supplement Oct 9, 2026 —
424B3 Prospectus Sep 8, 2026 —
S-3/A Filing Sep 3, 2026 —
S-3 Shelf registration Aug 27, 2026 —
424B4 Prospectus Jun 18, 2026 —
S-1/A Amended registration statement Jun 16, 2026 —
S-1 Registration statement Jun 12, 2026 —
S-8 Employee stock plan registration May 20, 2026 —
424B3 Prospectus May 14, 2026 —
S-1 Registration statement Apr 30, 2026 —
424B5 Prospectus supplement Oct 9, 2025 —
424B4 Prospectus Sep 30, 2025 —
S-1/A Amended registration statement Sep 25, 2025 —
S-1 Registration statement Sep 24, 2025 —
424B3 Prospectus Sep 18, 2025 —
S-1/A Amended registration statement Sep 15, 2025 —
S-1 Registration statement Aug 29, 2025 —
POS AM Filing Jun 27, 2025 —
POS AM Filing Jun 27, 2025 —
424B5 Prospectus supplement May 27, 2025 —
424B4 Prospectus May 7, 2025 —
S-1/A Amended registration statement May 5, 2025 —
S-1 Registration statement May 2, 2025 —
424B3 Prospectus Apr 22, 2025 —
S-1 Registration statement Apr 11, 2025 —
424B5 Prospectus supplement Feb 25, 2025 —
424B5 Prospectus supplement Feb 25, 2025 —
424B3 Prospectus Dec 9, 2024 —
S-1 Registration statement Nov 27, 2024 —
424B3 Prospectus Nov 22, 2024 —
424B3 Prospectus Nov 22, 2024 —
424B3 Prospectus Nov 22, 2024 —
424B5 Prospectus supplement Oct 21, 2024 —
424B3 Prospectus Sep 23, 2024 —
S-1 Registration statement Sep 11, 2024 —
424B3 Prospectus Aug 14, 2024 —
424B3 Prospectus Aug 14, 2024 —
424B5 Prospectus supplement Aug 5, 2024 —
424B5 Prospectus supplement Aug 2, 2024 —
S-8 Employee stock plan registration Jun 5, 2024 —
424B3 Prospectus May 22, 2024 —
424B3 Prospectus May 22, 2024 —
424B3 Prospectus Apr 17, 2024 —
POS AM Filing Apr 5, 2024 —
S-1 Registration statement Apr 4, 2024 —
POS AM Filing Apr 2, 2024 —
424B5 Prospectus supplement Mar 8, 2024 —
424B5 Prospectus supplement Mar 8, 2024 —
424B5 Prospectus supplement Nov 28, 2023 —
S-3 Shelf registration Nov 16, 2023 —
S-8 POS Filing Nov 3, 2023 —
S-8 Employee stock plan registration Oct 18, 2023 —
S-1 Registration statement Sep 20, 2023 —
S-8 Employee stock plan registration Apr 19, 2023 —
424B4 Prospectus Sep 2, 2022 —
S-1/A Amended registration statement Aug 18, 2022 —
S-1/A Amended registration statement Aug 5, 2022 —
S-1/A Amended registration statement Aug 2, 2022 —
S-1/A Amended registration statement Jul 28, 2022 —
S-1/A Amended registration statement Jun 16, 2022 —
FWP Free writing prospectus May 26, 2022 —
S-1/A Amended registration statement May 25, 2022 —
S-1 Registration statement Apr 25, 2022 —

Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
BIAF (Nasdaq), BIAFW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Antonio, TX
SEC filer status
, Emerging growth company
SEC CIK
1712762
Former names
bioAffinity Technologies, Inc. (until Nov 3, 2026)

Other Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.